Bellevue Group AG Sells 16,713 Shares of Phreesia, Inc. (NYSE:PHR)

Bellevue Group AG lowered its position in Phreesia, Inc. (NYSE:PHR - Free Report) by 4.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 405,693 shares of the company's stock after selling 16,713 shares during the period. Bellevue Group AG owned 0.70% of Phreesia worth $10,207,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in Phreesia by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company's stock worth $121,349,000 after purchasing an additional 61,048 shares in the last quarter. Greenhouse Funds LLLP grew its position in shares of Phreesia by 27.9% in the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company's stock worth $72,307,000 after buying an additional 626,579 shares during the period. Franklin Resources Inc. increased its stake in shares of Phreesia by 0.8% in the 4th quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company's stock worth $37,982,000 after acquiring an additional 11,986 shares in the last quarter. Northern Trust Corp lifted its position in Phreesia by 6.6% during the 4th quarter. Northern Trust Corp now owns 571,807 shares of the company's stock valued at $14,387,000 after acquiring an additional 35,392 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in Phreesia by 10.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock worth $12,415,000 after acquiring an additional 46,209 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company's stock.

Phreesia Stock Performance

PHR traded up $0.48 during mid-day trading on Friday, reaching $25.86. 625,161 shares of the company traded hands, compared to its average volume of 433,318. The stock has a market capitalization of $1.52 billion, a P/E ratio of -17.59 and a beta of 0.74. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The company's fifty day moving average price is $25.08 and its 200-day moving average price is $24.64.

Analyst Ratings Changes

A number of brokerages have weighed in on PHR. Citigroup raised their target price on shares of Phreesia from $31.00 to $35.00 and gave the company a "buy" rating in a research note on Friday, January 10th. Needham & Company LLC reiterated a "buy" rating and set a $29.00 price objective on shares of Phreesia in a research note on Thursday, March 13th. DA Davidson cut their target price on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. KeyCorp lowered their price target on Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Finally, Canaccord Genuity Group increased their price objective on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research report on Thursday, March 13th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of "Buy" and an average target price of $31.33.

Insider Activity at Phreesia

In other news, COO Evan Roberts sold 3,519 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $30.06, for a total transaction of $105,781.14. Following the completion of the sale, the chief operating officer now owns 741,197 shares of the company's stock, valued at $22,280,381.82. The trade was a 0.47 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Balaji Gandhi sold 28,759 shares of the firm's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $30.00, for a total value of $862,770.00. Following the completion of the transaction, the chief financial officer now directly owns 116,174 shares in the company, valued at approximately $3,485,220. This represents a 19.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 111,640 shares of company stock worth $3,094,167. 5.80% of the stock is owned by insiders.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.